14-104801669-A-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001137601.3(ZBTB42):āc.472A>Cā(p.Lys158Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000429 in 1,397,936 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001137601.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ZBTB42 | NM_001137601.3 | c.472A>C | p.Lys158Gln | missense_variant | 1/1 | ENST00000342537.8 | |
ZBTB42 | NM_001370342.1 | c.472A>C | p.Lys158Gln | missense_variant | 2/2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ZBTB42 | ENST00000342537.8 | c.472A>C | p.Lys158Gln | missense_variant | 1/1 | NM_001137601.3 | P1 | ||
ZBTB42 | ENST00000555360.1 | c.472A>C | p.Lys158Gln | missense_variant | 2/2 | 1 | P1 |
Frequencies
GnomAD3 genomes Cov.: 34
GnomAD3 exomes AF: 0.0000267 AC: 4AN: 149992Hom.: 0 AF XY: 0.0000125 AC XY: 1AN XY: 80124
GnomAD4 exome AF: 0.00000429 AC: 6AN: 1397936Hom.: 0 Cov.: 91 AF XY: 0.00000435 AC XY: 3AN XY: 689458
GnomAD4 genome Cov.: 34
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 09, 2023 | The c.472A>C (p.K158Q) alteration is located in exon 2 (coding exon 1) of the ZBTB42 gene. This alteration results from a A to C substitution at nucleotide position 472, causing the lysine (K) at amino acid position 158 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at